1.1. Research Methodology
1.2. Research Scope2. Disease Overview
2.1.1. Introduction
2.1.2. Classification
2.1.3. Symptoms
2.1.4. Causes
2.1.5. Diagnoses
2.1.6. Treatment
2.1.7. Epidemiology3. Executive Summary4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities5. Pipeline Analysis/Outlook
5.1. Analysis by Company
5.2. Analysis by Phase
5.2.1. Phase of Development
5.2.1.1. Introduction
5.2.1.1.1. Drug Profiling
- Drug Name
- Generic Name
- Synonyms
- Company
- Collaborator
- Route of administration
- Target
- Mechanism of Action
- Technology
- Molecule type
- CAS Number
- Weight
- Chemical Formula
- IUPAC name
- ATC code
5.2.1.1.2. Strategic Developments
5.2.1.1.3. Clinical trials
5.2.1.1.4. Clinical trial results
5.2.1.1.5. Patents
5.2.1.1.6. Technology
5.2.2. Comparative Analysis for Trials by Phase (Pie, Bar graph)
5.3. By Molecule type
5.4. Analysis by Region6. Company profiling
- Ipsen
- Novartis AG
- Chiasma, Inc.
- Strongbridge Biopharma plc
- Aspireo Pharmaceuticals Limited
- ITALFARMACO S.p.A.
- CRINETICS PHARMACEUTICALS
- Camurus AB
- Amryt Pharma plc
- Antisense Therapeutics Limited
- Midatech Pharma PLC
- TTY Biopharm
- Foresee Pharmaceuticals Co., Ltd.
- Bachem
- Peptron
- Aegis Therapeutics, LLC
- Aquestive Therapeutics
- Dauntless Pharmaceuticals
- DexTech Medical AB
- Ionis Pharmaceuticals, Inc.
- leon-nanodrugs GmbH
- Silence Therapeutics
For more information about this report visit https://www.researchandmarkets.com/research/7ss4zc/acromegaly?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.comFor E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/acromegaly-pipeline-analysis-2018-10-drugs-currently-in-different-phases-of-development-300658056.html
SOURCE Research and Markets
Related Links
http://www.researchandmarkets.com